TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
FLNA

Filana Therapeutics, Inc.

Healthcare · Biotechnology

0.7728$ -11.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Filana Therapeutics, Inc. (FLNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 104 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FLNA
Line item Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
224 158 141 135 130 118 108 104
203 137 120 115 109 98 88 84
149 129 117 112 106 96 87 83
149 129 117 112 106 96 87 83
6.3 0.9 0.9 0.8 0.8 0.1 0.1 –
0.1 0.0 – – – – – –
57 12 13 47 48 44 40 40
57 12 13 47 48 44 40 40
52 7.7 8.2 43 46 6.4 39 39
167 146 128 88 82 74 68 64
-378 -405 -429 -473 -484 -496 -506 -515
48 4,810 48 48 48 48 48 48

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?